Source: Annual Congress 2005 - Systemic effects of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Garrod, J. Marshall, G. W. Hagan, S. Fredericks, P. W. Jones (London, United Kingdom). Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD). Eur Respir J 2005; 26: Suppl. 49, 4197

Member's Comments

No comment yet.

Related content which might interest you: Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Correlation between pulmonary function test (PFT) parameters and quality of life (QoL) and dyspnea in stable chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007 Relationship between patient pulmonary function, exercise capacity and quality of life in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Functional illiteracy amongst those with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005 The state of patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 547s Year: 2007 Anxiety and low health status are predictors of exacerbations in patients with obstructive pulmonary disease Source: Annual Congress 2006 - Muscles, training and rehabilitation Year: 2006 The natural history of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=71 Year: 2006 Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Impact of exacerbations on COPD Source: Eur Respir Rev 2009; 19: 113-118 Year: 2010 Seasonal variations in exercise tolerance, activity and quality of life in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Subjective symptoms and functional performances in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Nursing challenges at home and in hospital Year: 2009 Impact of exacerbations in the natural course of COPD Source: Eur Respir Monogr 2013; 60: 84-95 Year: 2013 Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Smoking abstinence in patients with chronic airway obstructive disease Source: Annual Congress 2006 - How to treat tobacco smokers Year: 2006 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006